Delivery Order SPE2DB25D3306-SPE2DB25FUCLV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,578.64 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a ciprofloxacin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The Defense Logistics Agency awarded a $3,362.37 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units). This firm fixed-price contract, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The antibiotic pharmaceutical product supports federal medical procurement requirements for military and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packaging) under a firm fixed price contract valued at $2,466.80. This delivery order, which was not set-aside, is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction for pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,761.03 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ciprofloxacin Hydrochloride, a broad-spectrum antibiotic commonly used for bacterial infections in military and veteran healthcare settings. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCLVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical supplier of medications and medical supplies to Defense Health Agency, military healthcare systems, and other federal agencies worldwide. The company's contract portfolio demonstrates extensive federal procurement experience across multiple therapeutic domains, supporting global military healthcare operations and veteran medical systems through its flexible delivery order vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/31/25 |